Advanced Elementary...
Health Care: Drugs
Delcath Systems Inc. (DCTH: NASDAQ)
$0.47 0.02 | 3.71%
06/19/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -51.87M | -30.88M | -46.68M | -22.06M |
| Operating Gains/Losses | 0.00 | 0.00 | 6.73K | 3.44K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -144.00K | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | -1.10M | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 331.00K | 3.21M | 1.35M | 1.14M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 9.00K | 26.00K | 300.00K | 0.00 |
| Other Non-Cash Items | 1.67M | -11.31M | 21.46M | 10.88M |
| Net Cash From Continuing Operations | -50.01M | -37.37M | -24.08M | -10.46M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -50.01M | -37.37M | -24.08M | -10.46M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 200.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 4.98M | 1.49M | 1.74M | 4.05M |
| Purchases of Property, Plant & Equipment | -2.12M | -2.61M | -1.64M | -515.44K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | -4.98M | -3.24M | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 2.86M | -6.10M | -3.13M | 3.53M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 45.06M | 23.62M | 37.35M | 35.48M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 45.06M | 23.62M | 37.35M | 35.48M |
| Effect of Exchange Rate Changes | 37.00K | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -2.05M | -19.84M | 10.14M | 28.55M |
Portfolios with DCTH
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserMy Portfolio
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
Latest DCTH Headlines from TheStreet
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Biotech Stock Mailbag: Delcath, Navidea, Affymax, Ziopharm 03.15.13 | 06:03 am
- Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
- Play TheStreet's FDA Drug Approval Contest 03.05.13 | 12:03 pm
- 3 Pharma Stocks Under $5 Trading Higher 01.15.13 | 02:01 pm
- 2013 FDA Drug Approval Decision Calendar 12.19.12 | 09:12 am
- Biotech Stock Mailbag: YM Bio, Infinity, Delcath and Galena 12.07.12 | 07:12 am
- AP Pharma, Delcath Systems: FDA 'Acceptance' Run-Up Trades 10.09.12 | 07:10 am
- 3 Health Care Stocks Under $10 Making Big Moves 10.02.12 | 02:10 pm
- Biotech Stock Mailbag: Oncolytics, Sarepta, Delcath, Peregrine 08.24.12 | 06:08 am
Press Releases for DCTH
- Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors Of Upcoming Deadlines In Shareholder Litigation Involving Delcath Systems, Inc., Amyris, Inc., Nam Tai Electronics, Inc. And Accretive Health, Inc. - Business Wire 06.18.13 | 10:06 am
- Law Offices Of Todd M. Garber Announces Class Action Lawsuit Against Delcath Systems, Inc. - Business Wire 06.17.13 | 09:06 am
- Lifshitz Law Firm Announces Investigation Of Aruba Networks, Inc., Delcath Systems, Inc., And Digital Generation, Inc. - PR Newswire 05.28.13 | 09:05 pm
- Record Use Of At-the-Market (ATM) Offerings Continues In 2013 With $161 Million Raised By U.S. Life Sciences Companies In First Quarter, Reports Brinson Patrick - PR Newswire 05.28.13 | 08:05 am
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Delcath Systems, Inc. To Contact The Firm - PR Newswire 05.18.13 | 09:05 am
- Delcath Systems, Inc. Sued By Investor - PR Newswire 05.10.13 | 07:05 pm
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Delcath Systems, Inc. - PR Newswire 05.03.13 | 08:05 am
- Delcath To Present At JMP Securities Healthcare Conference On July 12 - PR Newswire 07.09.12 | 04:07 pm
- Delcath Announces First CHEMOSAT Procedures In Germany - PR Newswire 02.27.12 | 06:02 am
- Delcath Announces Updated Efficacy Results From Phase 3 Trial Of Chemosaturation For Melanoma Metastases In The Liver Presented At European Multidisciplinary Cancer Congress - PR Newswire 09.23.11 | 06:09 pm
Partner Headlines for DCTH
- The ODAC Postmortem: Lessons Learned Part 2, Delcath Systems - Seeking Alpha 05.06.13 | 09:05 am
- Is Delcath The Post-Celsion Play On Liver Cancer? - Seeking Alpha 02.04.13 | 09:02 am
- Morning Market Losers - Benzinga 10.15.12 | 09:10 am
- Benzinga's Microcap Movers for Friday October 5, 2012 - Benzinga 10.06.12 | 06:10 pm
- Delcath Systems: An Exclusive Interview With ROTH Capital Senior Analyst - Seeking Alpha 09.28.12 | 09:09 am
- Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO - GuruFocus 06.11.12 | 01:06 pm
- Active Stock Alerts: Dendreon, Delcath Systems, Johnson & Johnson, Boeing, Onyx June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- Hyper-Novel Investments For Targeting Cancer - Seeking Alpha 05.30.12 | 09:05 am
- Mid-Day Update: Stocks Trending Water Ahead of First Holiday Weekend of Summer - NASDAQ 05.25.12 | 04:05 pm
- Mid-Day Market Losers - Benzinga 05.25.12 | 01:05 pm
